Weiwei An

941 total citations
21 papers, 658 citations indexed

About

Weiwei An is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weiwei An has authored 21 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Weiwei An's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Beetle Biology and Toxicology Studies (3 papers). Weiwei An is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Beetle Biology and Toxicology Studies (3 papers). Weiwei An collaborates with scholars based in China, Japan and United States. Weiwei An's co-authors include Yue Yang, Pengxiang Yang, Jing Jie, Qingyuan Zhang, Minwei Wang, Takashi Ikejima, Shin‐ichi Tashiro, Yihua Zhu, Lihong Wang and Satoshi Onodera and has published in prestigious journals such as Bioinformatics, PLoS ONE and Scientific Reports.

In The Last Decade

Weiwei An

21 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei An China 11 450 382 107 106 84 21 658
Damien Destouches France 13 439 1.0× 150 0.4× 142 1.3× 62 0.6× 56 0.7× 21 621
Yunfei Wen United States 12 389 0.9× 169 0.4× 121 1.1× 105 1.0× 70 0.8× 23 675
Luke Gubbins Ireland 5 377 0.8× 239 0.6× 166 1.6× 51 0.5× 77 0.9× 6 543
Christian Schmithals Germany 12 313 0.7× 192 0.5× 61 0.6× 68 0.6× 41 0.5× 18 478
Mi-Ran Choi United States 11 239 0.5× 112 0.3× 134 1.3× 137 1.3× 89 1.1× 16 528
Xuejiao Shi China 12 406 0.9× 224 0.6× 83 0.8× 46 0.4× 58 0.7× 26 558
Alvin J.O. Almodovar United States 6 225 0.5× 152 0.4× 84 0.8× 80 0.8× 28 0.3× 9 366
Jennifer M. Wymant United Kingdom 7 377 0.8× 251 0.7× 85 0.8× 159 1.5× 49 0.6× 7 605
Amanda Poissonnier France 5 338 0.8× 174 0.5× 151 1.4× 101 1.0× 144 1.7× 7 516
Zeqian Yu China 10 204 0.5× 173 0.5× 121 1.1× 41 0.4× 49 0.6× 17 361

Countries citing papers authored by Weiwei An

Since Specialization
Citations

This map shows the geographic impact of Weiwei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei An more than expected).

Fields of papers citing papers by Weiwei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei An. The network helps show where Weiwei An may publish in the future.

Co-authorship network of co-authors of Weiwei An

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei An. A scholar is included among the top collaborators of Weiwei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei An. Weiwei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Leting, Shu‐Yuan Chen, Xi Li, et al.. (2024). Tree shrews as a new animal model for systemic sclerosis research. Frontiers in Immunology. 15. 1315198–1315198. 1 indexed citations
2.
Zheng, Leting, et al.. (2023). A meta-analysis of the clinical significance of neutrophil-to-lymphocyte ratios in interstitial lung disease. PLoS ONE. 18(6). e0286956–e0286956. 9 indexed citations
3.
Yuan, Lili, et al.. (2023). Associations between marital quality and the prognosis of breast cancer in young Chinese women: 10.3-year median follow-up. Chinese Clinical Oncology. 12(5). 51–51. 1 indexed citations
4.
Song, Yang, Weiwei An, Hongmei Wang, et al.. (2021). LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer. Frontiers in Cell and Developmental Biology. 9. 643522–643522. 7 indexed citations
5.
Yang, Pengxiang, Xingjian Cao, Xiang Chen, et al.. (2020). The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth. Cellular Immunology. 360. 104262–104262. 142 indexed citations
6.
Yang, Pengxiang, Xingjian Cao, Xiang Chen, et al.. (2020). Upregulation of microRNA-155 Enhanced Migration and Function of Dendritic Cells in Three-dimensional Breast Cancer Microenvironment. Immunological Investigations. 50(8). 1058–1071. 8 indexed citations
7.
Huang, Lan, Hongfei Ji, Lei Yin, et al.. (2019). High Expression of Plakoglobin Promotes Metastasis in Invasive Micropapillary Carcinoma of the Breast via Tumor Cluster Formation. Journal of Cancer. 10(12). 2800–2810. 23 indexed citations
8.
Ma, Jianli, Yue Yang, Xiaoyu Zhai, et al.. (2018). LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1. Biochemical and Biophysical Research Communications. 500(3). 614–620. 35 indexed citations
9.
Niu, Xingjian, Hongfei Ji, Yiran Wang, et al.. (2018). Systemic immune response associated with radiation therapy in B‑cell non‑Hodgkin's lymphoma of Waldeyer's ring. Oncology Reports. 40(6). 3674–3684. 3 indexed citations
10.
Kang, Xinmei, Xingjian Niu, Weiwei An, et al.. (2017). Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer. Scientific Reports. 7(1). 42069–42069. 68 indexed citations
11.
Luan, Tian, Ximei Zhang, Shuyuan Wang, et al.. (2017). Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p. Oncotarget. 8(44). 76153–76164. 99 indexed citations
12.
Dai, Enyu, Feng Yang, Xu Zhou, et al.. (2017). ncDR: a comprehensive resource of non-coding RNAs involved in drug resistance. Bioinformatics. 33(24). 4010–4011. 57 indexed citations
13.
Yang, Pengxiang, Yue Yang, Weiwei An, et al.. (2016). The long noncoding RNA‐ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR‐145 pathway. Journal of Gastroenterology and Hepatology. 32(4). 837–845. 87 indexed citations
14.
Meng, Dali, et al.. (2013). Four new quassinoids from the roots of Eurycoma longifolia Jack. Fitoterapia. 92. 105–110. 30 indexed citations
15.
An, Weiwei, et al.. (2011). [A cross-sectional study on health-related knowledge and skills and its influencing factors among the Chinese college students].. PubMed. 32(8). 781–5. 2 indexed citations
16.
Li, Tao, et al.. (2010). Genetic diversity of different geographical populations of <I>Oxya chinensis</I> based on AFLP analysis. Hereditas (Beijing). 32(2). 163–169. 1 indexed citations
17.
Yang, Wei, et al.. (2006). Capsaicin Induces Apoptosis in HeLa Cells via Bax/Bcl-2 and Caspase-3 Pathways. 亚洲传统医药. 1. 159–165. 4 indexed citations
18.
An, Weiwei, Minwei Wang, Shin‐ichi Tashiro, Satoshi Onodera, & Takashi Ikejima. (2005). Mitogen-activated protein kinase-dependent apoptosis in norcan-tharidin-treated A375-S2 cells is proceeded by the activation of protein kinase C.. PubMed. 118(3). 198–203. 20 indexed citations
19.
An, Weiwei, Minwei Wang, Shin‐ichi Tashiro, Satoshi Onodera, & Takashi Ikejima. (2004). Norcantharidin Induces Human Melanoma A375-S2 Cell Apoptosis through Mitochondrial and Caspase Pathways. Journal of Korean Medical Science. 19(4). 560–560. 31 indexed citations
20.
An, Weiwei, Xian-Feng Gong, Minwei Wang, et al.. (2004). Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.. PubMed. 25(11). 1502–8. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damien Destouches Breakdown of academic impact, for papers by Yunfei Wen Breakdown of academic impact, for papers by Luke Gubbins Breakdown of academic impact, for papers by Christian Schmithals Breakdown of academic impact, for papers by Mi-Ran Choi Breakdown of academic impact, for papers by Xuejiao Shi Breakdown of academic impact, for papers by Alvin J.O. Almodovar Breakdown of academic impact, for papers by Jennifer M. Wymant Breakdown of academic impact, for papers by Amanda Poissonnier Breakdown of academic impact, for papers by Zeqian Yu
Rankless by CCL
2026